InnovAge Holding financials
$8.98+1.01%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Jun 30 | FY25 Jun 30 | FY24 Jun 30 | FY23 Jun 30 | FY22 Jun 30 | FY21 Jun 30 |
|---|---|---|---|---|---|---|
| Revenue | $989.7M | $853.7M | $763.9M | $688.1M | $698.6M | $637.8M |
| Gross profit | $227.8M | $153.6M | $132.1M | $313.6M | $698.6M | $637.8M |
| Gross margin | 23.0% | 18.0% | 17.3% | 45.6% | 100.0% | 100.0% |
| Operating income | $2.6M | -$29.8M | -$23.2M | -$49.4M | -$4.4M | -$11.0M |
| Net income | -$2.5M | -$30.3M | -$21.3M | -$40.7M | -$6.5M | -$44.0M |
| Net margin | −0.3% | −3.6% | −2.8% | −5.9% | −0.9% | −6.9% |
| Diluted EPS | $-0.02 | $-0.22 | $-0.16 | $-0.30 | $-0.05 | $-0.36 |
| EBITDA | $26.9M | $3.4M | -$4.2M | -$34.0M | $9.5M | $1.3M |
| Operating cash flow | $64.7M | $32.9M | -$36.9M | $20.2M | $27.3M | -$7.5M |
| Free cash flow | $50.4M | $26.6M | -$44.8M | -$3.1M | -$10.9M | -$25.1M |
| Diluted shares | 135.7M | 135.4M | 135.9M | 135.6M | 135.5M | 123.6M |
Balance sheet
| Period end | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $97.9M | $64.1M | $56.9M | $127.2M | $184.4M | $201.5M |
| Short-term investments | $43.4M | $41.8M | $45.8M | $46.2M | $0.00 | — |
| Total debt | $62.6M | $72.5M | $82.6M | $86.5M | $84.8M | $82.6M |
| Total assets | $557.4M | $526.9M | $547.7M | $567.4M | $555.6M | $531.8M |
| Total liabilities | $288.6M | $263.9M | $247.9M | $252.6M | $201.9M | $173.8M |
| Shareholders' equity | $238.8M | $237.9M | $277.6M | $302.1M | $338.5M | $341.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology